Pregled bibliografske jedinice broj: 1198407
The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review.
The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review. // Obesity surgery, 24 (2014), 2; 310-323 doi:10.1007/s11695-013-1137-2 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1198407 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The duodenal-jejunal bypass liner for the
treatment of type 2 diabetes mellitus and/or
obesity: a systematic review.
Autori
Zechmeister-Koss, Ingrid ; Huić, Mirjana ; Fischer, Stefan
Izvornik
Obesity surgery (0960-8923) 24
(2014), 2;
310-323
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
duodenal-jejunal bypass liner ; type 2 diabetes mellitus ; obesity ; systematic review
Sažetak
This systematic literature review applies the GRADE approach to evaluate the efficacy and safety of the duodenal-jejunal bypass liner (DJBL) for the treatment of (a) patients with obesity ≥ grade II (with comorbidities) and (b) patients with type 2 diabetes mellitus + obesity ≥ grade I. We included ten studies with a total of 342 patients that primarily investigated a prototype of the DJBL. In high-grade obese patients, short-term excess weight loss was observed. For the remaining patient-relevant endpoints and patient populations, evidence was either not available or ambiguous. Complications (mostly minor) occurred in 64-100% of DJBL patients compared to 0-27% in the control groups. Gastrointestinal bleeding was observed in 4% of patients. We do not yet recommend the device for routine use.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE